Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections
NCT01844856Phase 3Completed
- Sponsor
- Tetraphase Therapeutics
- Start
- Aug 2013
- Primary completion
- Aug 2014
- Modality
- Orthosteric Ligands
- Countries
- 13
01
Overview
Phase 3, randomised, double-blind trial of eravacycline in Intra-abdominal infection (IAI) (2 arms), sponsored by Tetraphase Therapeutics. Primary endpoint: Clinical Response at Test-of-Cure (TOC) Visit. Started Aug 2013; status: completed.
02
Drugs
eravacycline
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT01844856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01844856.